Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01033734 · ClinicalTrials.gov registry record · Phase 1
A Study of Intravenous Tamiflu (Oseltamivir) in Children With Influenza
A Phase 1 study of Influenza, sponsored by Hoffmann-La Roche.
- Completed
- Registry status
- Phase 1
- Development phase
- 8
- Enrollment target
- 20
- Study locations
NCT01033734: Completed Phase 1 study of Influenza, sponsored by Hoffmann-La Roche.
NCT01033734 is a Phase 1 study of Influenza that has completed, run by Hoffmann-La Roche. The registered enrollment target is 8 participants, below the 36,804-participant average among 156 other Influenza trials with a reported enrollment target (100% lower). The trial reports 20 study locations across 14 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01033734, a Phase 1 study of Influenza, has completed, sponsored by Hoffmann-La Roche.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 8 participants
- Enrollment target
- 20
- Study locations
Study Summary
This open-label study will assess the pharmacokinetics/pharmacodynamics and safety of intravenous (iv) Tamiflu (oseltamivir) in 3 cohorts of children, aged 6-12, 3-5 and 1-2 years, with influenza infection. Patients will receive iv Tamiflu therapy for 5 days (10 doses). For patients whose conditions no longer merit continued iv dosing, therapy may be switched to oral Tamiflu to complete their prescribed course of treatment. If medically necessary, iv or oral therapy with Tamiflu may be continued for up to 5 additional days. Anticipated time on study treatment is 5 to 10 days.
Conditions Studied
Interventions
- DRUG oseltamivir [Tamiflu]
Study Locations (20)
Massachusetts
- - Boston
- - Boston
- - Boston
- - Springfield
New York
- - Brooklyn
- - New York
- - Stony Brook
California
- - Los Angeles
- - Oakland
Colorado
- - Aurora
Delaware
- - Wilmington
Florida
- - Jacksonville
Illinois
- - Chicago
Indiana
- - South Bend
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2010-12 |
| Est. Completion | 2012-12 |
| Phase | Phase 1 |
What the finished NCT01033734 record still lists
NCT01033734 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 36,804-participant average among 156 other Influenza trials with a reported enrollment target (100% lower).
The record links to 1 condition, with Influenza appearing as the primary indexed condition, and to 1 intervention - of which oseltamivir [Tamiflu] is the first listed.
NCT01033734 names 20 study sites across 14 states, led by Massachusetts, New York, California.
Frequently Asked Questions
What is clinical trial NCT01033734 about?
NCT01033734 is a clinical study titled "A Study of Intravenous Tamiflu (Oseltamivir) in Children With Influenza". This open-label study will assess the pharmacokinetics/pharmacodynamics and safety of intravenous (iv) Tamiflu (oseltamivir) in 3 cohorts of children, aged 6-12, 3-5 and 1-2 years, with influenza infection. Patients will receive iv Tamiflu therapy for 5 days (10 doses). For patients whose conditions...
What is the current status of trial NCT01033734?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 8 participants. The study started on 2010-12. Estimated completion is 2012-12.
What conditions does trial NCT01033734 study?
This clinical trial studies the following conditions: Influenza.
What interventions are being tested in trial NCT01033734?
The interventions under investigation include: oseltamivir [Tamiflu] (DRUG).
Who is sponsoring clinical trial NCT01033734?
This trial is sponsored by Hoffmann-La Roche, which has 909 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01033734 being conducted?
This trial has 20 study locations across California, Colorado, Delaware, Florida, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Influenza
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01033734's enrollment target sits among peer trials
8 155th of 156 higher than 2 of 156 other Influenza trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Influenza trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
pH1N1 Blinded Challenge Study
RECRUITING · Phase 1
-
A/Texas Flu Challenge
RECRUITING · Phase 1
-
First-in-Human Study of VNT-101: Safety, Tolerability, and Pharmacokinetics
RECRUITING · Phase 1
-
Influenza Human Challenge Model
RECRUITING · Phase 1
-
A Study to Evaluate the Safety and Immunogenicity of Two Doses of DCVC H1 HA mRNA-LNP in Healthy Adults
ACTIVE NOT RECRUITING · Phase 1
-
Pilot Influenza Challenge Study
ACTIVE NOT RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia